{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:59:14Z","timestamp":1790715554277,"version":"4.1.0"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01 HD036071"],"award-info":[{"award-number":["R01 HD036071"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54 HD079125"],"award-info":[{"award-number":["U54 HD079125"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2018.00564","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T03:13:25Z","timestamp":1542078805000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":186,"title":["Fragile X-Associated Neuropsychiatric Disorders (FXAND)"],"prefix":"10.3389","volume":"9","author":[{"given":"Randi J.","family":"Hagerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Protic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Rajaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Salcedo-Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elber Yuksel","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","article-title":"Fragile X syndrome","volume":"3","author":"Hagerman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.biopsych.2011.05.033","article-title":"Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation","volume":"70","author":"Hessl","year":"2011","journal-title":"Biol Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/jmedgenet-2013-102021","article-title":"CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles","volume":"51","author":"Pretto","year":"2014","journal-title":"J Med Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1093\/hmg\/ddu032","article-title":"CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size","volume":"23","author":"Ludwig","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population","volume":"291","author":"Jacquemont","year":"2004","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/ejhg.2009.51","article-title":"Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families","volume":"17","author":"Rodriguez-Revenga","year":"2009","journal-title":"Eur J Hum Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/gm401","article-title":"FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States","volume":"4","author":"Tassone","year":"2012","journal-title":"Genome Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome","volume":"66","author":"Tassone","year":"2000","journal-title":"Am J Hum Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/nyas.12693","article-title":"Fragile X-associated tremor\/ataxia syndrome","volume":"1338","author":"Hagerman","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/hmg\/ddp479","article-title":"Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration","volume":"19","author":"Chen","year":"2010","journal-title":"Hum Mol Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","article-title":"Fragile X-associated temor\/ataxia syndrome - features, mechanisms and management","volume":"12","author":"Hagerman","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/hmg\/ddx148","article-title":"Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of fragile X-associated tremor\/ataxia syndrome","volume":"26","author":"Robin","year":"2017","journal-title":"Hum Mol Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fnins.2016.00159","article-title":"Premutation in the fragile X mental retardation 1 (FMR1) gene affects maternal Zn-milk and perinatal brain bioenergetics and scaffolding","volume":"10","author":"Napoli","year":"2016","journal-title":"Front Neurosci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1093\/hmg\/ddr211","article-title":"Altered zinc transport disrupts mitochondrial protein processing\/import in fragile X-associated tremor\/ataxia syndrome","volume":"20","author":"Napoli","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","article-title":"CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome","volume":"78","author":"Todd","year":"2013","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2310\/JIM.0b013e3181af59c4","article-title":"Fragile X-associated Tremor\/Ataxia Syndrome (FXTAS): Clinical Phenotype, Diagnosis and Treatment","volume":"57","author":"Leehey","year":"2009","journal-title":"J Investig Med."},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-33898-9","volume-title":"FXTAS, FXPOI, and Other Premutation Disorders","author":"Tassone","year":"2016"},{"key":"B18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/brain\/awh683","article-title":"Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"129","author":"Greco","year":"2006","journal-title":"Brain"},{"key":"B19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00401-011-0860-9","article-title":"Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor\/ataxia syndrome and CGG knock-in mice","volume":"122","author":"Hunsaker","year":"2011","journal-title":"Acta Neuropathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2174\/157340013805289635","article-title":"Cognitive dysfunction in Fmr1 premutation carriers","volume":"9","author":"Seritan","year":"2013","journal-title":"Curr Psychiatry Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1042\/BJ20091960","article-title":"Evidence of mitochondrial dysfunction in fragile X-associated tremor\/ataxia syndrome","volume":"429","author":"Ross-Inta","year":"2010","journal-title":"Biomed J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainres.2014.11.058","article-title":"Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor\/ataxia syndrome","volume":"1598","author":"Ariza","year":"2015","journal-title":"Brain Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13311-014-0292-z","article-title":"Repeat-associated non-AUG translation and its impact in neurodegenerative disease","volume":"11","author":"Kearse","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2017.03.018","article-title":"Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation","volume":"55","author":"Wang","year":"2017","journal-title":"Neurobiol Aging"},{"key":"B25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1866-1955-6-29","article-title":"Visual motion processing deficits in infants with the fragile X premutation","volume":"6","author":"Gallego","year":"2014","journal-title":"J Neurodev Disord"},{"key":"B26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s11689-016-9171-8","article-title":"Developmental profiles of infants with an FMR1 premutation","volume":"8","author":"Wheeler","year":"2016","journal-title":"J Neurodev Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1097\/00004703-200604002-00012","article-title":"Autism spectrum disorders and attention-deficit\/hyperactivity disorder in boys with the fragile X premutation","volume":"27","author":"Farzin","year":"2006","journal-title":"J Dev Behav Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s10803-006-0205-z","article-title":"Autism spectrum phenotype in males and females with fragile X full mutation and premutation","volume":"37","author":"Clifford","year":"2007","journal-title":"J Autism Dev Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00439-011-1106-6","article-title":"Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder","volume":"131","author":"Chonchaiya","year":"2012","journal-title":"Hum Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S1474-4422(13)70125-X","article-title":"Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor\/ataxia syndrome","volume":"12","author":"Hagerman","year":"2013","journal-title":"Lancet Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/13854046.2016.1189536","article-title":"Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation","volume":"30","author":"Schneider","year":"2016","journal-title":"Clin Neuropsychol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2119\/molmed.2016.00122","article-title":"Altered redox mitochondrial biology in the neurodegenerative disorder fragile X-tremor\/ataxia syndrome: use of antioxidants in precision medicine","volume":"22","author":"Song","year":"2016","journal-title":"Mol Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fnmol.2016.00071","article-title":"Plasma biomarkers for monitoring brain pathophysiology in FMR1 premutation carriers","volume":"9","author":"Giulivi","year":"2016","journal-title":"Front Mol Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/157340013805289699","article-title":"Psychiatric disorders associated with Fxtas","volume":"9","author":"Seritan","year":"2013","journal-title":"Curr Psychiatry Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.genhosppsych.2007.03.003","article-title":"Cognitive, anxiety and mood disorders in the fragile X-associated tremor\/ataxia syndrome","volume":"29","author":"Bourgeois","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1866-1955-6-25","article-title":"Mouse models of the fragile X premutation and fragile X-associated tremor\/ataxia syndrome","volume":"6","author":"Berman","year":"2014","journal-title":"J Neurodev Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5582\/irdr.2015.01029","article-title":"Anxiety disorders in fragile X premutation carriers: preliminary characterization of probands and non-probands","volume":"4","author":"Cordeiro","year":"2015","journal-title":"Intractable Rare Dis Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K","article-title":"Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report","volume":"83","author":"Miller","year":"1999","journal-title":"Am J Med Genet A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1152\/jn.00730.2012","article-title":"Abnormal GABA-mediated and cerebellar inhibition in women with the fragile X premutation","volume":"109","author":"Conde","year":"2013","journal-title":"J Neurophysiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"13831","DOI":"10.1074\/jbc.M112.441055","article-title":"Enhanced asynchronous Ca(2+) oscillations associated with impaired glutamate transport in cortical astrocytes expressing Fmr1 gene premutation expansion","volume":"288","author":"Cao","year":"2013","journal-title":"J Biol Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/hmg\/dds118","article-title":"Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone","volume":"21","author":"Cao","year":"2012","journal-title":"Hum Mol Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.neurobiolaging.2013.11.009","article-title":"Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor\/ataxia syndrome","volume":"35","author":"Pretto","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B43","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/brain\/awl338","article-title":"Amygdala dysfunction in men with the fragile X premutation","volume":"130","author":"Hessl","year":"2007","journal-title":"Brain"},{"key":"B44","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/ajmg.b.32196","article-title":"High rates of comorbid depressive and anxiety disorders among women with premutation of the FMR1 gene","author":"Kenna","year":"2013","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4088\/JCP.09m05407blu","article-title":"Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers","volume":"72","author":"Bourgeois","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ajmg.b.30786","article-title":"Mood and anxiety disorders in females with the FMR1 premutation","author":"Roberts","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157340013805289662","article-title":"Ages of onset of mood and anxiety disorders in fragile X premutation carriers","volume":"9","author":"Seritan","year":"2013","journal-title":"Curr Psychiatry Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ajmg.1561","article-title":"Neurobehavioral phenotype in carriers of the fragile X premutation","volume":"103","author":"Johnston","year":"2001","journal-title":"Am J Med Genet"},{"key":"B49","volume-title":"Administration, Scoring and Procedures Manual","author":"Derogatis","year":"1997"},{"key":"B50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10519-008-9214-3","article-title":"Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers","volume":"38","author":"Hunter","year":"2008","journal-title":"Behav Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/humrep\/deh635","article-title":"Association of FMR1 repeat size with ovarian dysfunction","volume":"20","author":"Sullivan","year":"2005","journal-title":"Hum Reprod."},{"key":"B52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ajmg.b.32529","article-title":"FMR1 genotype interacts with parenting stress to shape health and functional abilities in older age","volume":"174","author":"Mailick","year":"2017","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10519-011-9520-z","article-title":"The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance","volume":"42","author":"Hunter","year":"2012","journal-title":"Behav Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1352\/0895-8017(2004)109<237:PWACIM>2.0.CO;2","article-title":"Psychological well-being and coping in mothers of youths with autism, Down syndrome, or fragile X syndrome","volume":"109","author":"Abbeduto","year":"2004","journal-title":"Am J Ment Retard."},{"key":"B55","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1365-2788.2006.00907.x","article-title":"Psychological well-being of mothers of youth with fragile X syndrome: syndrome specificity and within-syndrome variability","volume":"50","author":"Lewis","year":"2006","journal-title":"J Intellect Disabil Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1037\/a0026528","article-title":"Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome","volume":"31","author":"Seltzer","year":"2012","journal-title":"Health Psychol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/DBP.0b013e318272dcbc","article-title":"Health and economic consequences of fragile X syndrome for caregivers","volume":"33","author":"Bailey","year":"2012","journal-title":"J Dev Behav Pediatr."},{"key":"B58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.neubiorev.2013.01.010","article-title":"Neurobehavioural evidence for the involvement of the FMR1 gene in female carriers of fragile X syndrome","volume":"37","author":"Kraan","year":"2013","journal-title":"Neurosci Biobehav Rev."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/ajmg.b.32496","article-title":"Psychiatric disorders among women with the fragile X premutation without children affected by fragile X syndrome","volume":"171","author":"Gossett","year":"2016","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/jir.12409","article-title":"The effects of optimism, religion, and hope on mood and anxiety disorders in women with the FMR1 premutation","volume":"61","author":"Lowell","year":"2017","journal-title":"J Intellect Disabil Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1000119","DOI":"10.4172\/2168-975X.1000119","article-title":"Molecular advances leading to treatment implications for fragile X premutation carriers","volume":"3","author":"Polussa","year":"2014","journal-title":"Brain Disord Ther"},{"key":"B63","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2217\/fnl.14.11","article-title":"Towards an understanding of neuropsychiatric manifestations in fragile X premutation carriers","volume":"9","author":"Besterman","year":"2014","journal-title":"Future Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/ajmg.a.32439","article-title":"Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey","author":"Bailey","year":"2008","journal-title":"Am J Med Genet A"},{"key":"B65","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/00004583-199402000-00015","article-title":"Behavioral and psychiatric disorders in adult male carriers of fragile X","volume":"33","author":"Dorn","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B66","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/ajmg.b.30685","article-title":"Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor\/Ataxia syndrome: a controlled study","author":"Kogan","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1399-0004.2011.01675.x","article-title":"Fragile X-associated tremor\/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene","volume":"82","author":"Loesch","year":"2012","journal-title":"Clin Genet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"PCC.12l01492","DOI":"10.4088\/PCC.12l01492","article-title":"Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders","volume":"15","author":"Schneider","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"key":"B69","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5582\/irdr.2014.01023","article-title":"Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: a report of two cases","volume":"3","author":"Muzar","year":"2014","journal-title":"Intractable Rare Dis Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ajmg.a.32060","article-title":"Expanded clinical phenotype of women with the FMR1 premutation","author":"Coffey","year":"2008","journal-title":"Am J Med Genet A"},{"key":"B71","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/cge.12109","article-title":"Prevalence and risk of migraine headaches in adult fragile X premutation carriers","volume":"84","author":"Au","year":"2013","journal-title":"Clin Genet."},{"key":"B72","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/glia.22327","article-title":"Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse","volume":"60","author":"Alfonso-Loeches","year":"2012","journal-title":"Glia"},{"key":"B73","doi-asserted-by":"publisher","first-page":"8285","DOI":"10.1523\/JNEUROSCI.0976-10.2010","article-title":"Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage","volume":"30","author":"Alfonso-Loeches","year":"2010","journal-title":"J Neurosci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"E181","DOI":"10.1111\/j.1530-0277.2012.01920.x","article-title":"Longitudinal changes in white matter integrity among adolescent substance users","volume":"37","author":"Bava","year":"2013","journal-title":"Alcohol Clin Exp Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/jcbfm.2009.112","article-title":"Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells","volume":"29","author":"Ramirez","year":"2009","journal-title":"J Cereb Blood Flow Metab."},{"key":"B76","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1471-4159.2010.06794.x","article-title":"Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate","volume":"114","author":"Muriach","year":"2010","journal-title":"J Neurochem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1165\/ajrcmb.20.6.3424","article-title":"Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids","volume":"20","author":"Sarafian","year":"1999","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/ajmg.a.37030","article-title":"Methadone use in a male with the FMRI premutation and FXTAS","volume":"167","author":"Muzar","year":"2015","journal-title":"Am J Med Genet A"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1093\/rheumatology\/ker273","article-title":"Fibromyalgia in fragile X mental retardation 1 gene premutation carriers","volume":"50","author":"Leehey","year":"2011","journal-title":"Rheumatology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pscychresns.2004.04.001","article-title":"White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects","volume":"131","author":"Lyoo","year":"2004","journal-title":"Psychiatry Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1369-1600.2010.00266.x","article-title":"White matter microstructure in opiate addiction","volume":"17","author":"Bora","year":"2012","journal-title":"Addict Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e33809","DOI":"10.1371\/journal.pone.0033809","article-title":"White matter abnormalities correlating with memory and depression in heroin users under methadone maintenance treatment","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS ONE"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/sj.bjp.0704364","article-title":"Chronic morhpine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain","volume":"134","author":"Boronat","year":"2001","journal-title":"Br J Pharmacol."},{"key":"B84","first-page":"1","article-title":"Fentanyl Overdose in a female with the FMR1 premutation and FXTAS","volume":"1","author":"El-Deeb","year":"2018","journal-title":"J Mol Genet"},{"key":"B85","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/21641846.2014.881155","article-title":"Fatigue and body mass index in the Fragile X premutation carrier","volume":"2","author":"Summers","year":"2014","journal-title":"Fatigue Biomedi Health Behav."},{"key":"B86","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4088\/PCC.v10n0206","article-title":"A systematic review of chronic fatigue syndrome: don't assume it's depression","volume":"10","author":"Griffith","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"B87","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/ajmg.b.31237","article-title":"Sleep apnea in fragile X premutation carriers with and without FXTAS","author":"Hamlin","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B88","doi-asserted-by":"publisher","first-page":"852","DOI":"10.4088\/JCP.08r04476","article-title":"A review of fragile X premutation disorders: expanding the psychiatric perspective","volume":"70","author":"Bourgeois","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"B89","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1399-0004.2010.01448.x","article-title":"Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome","volume":"78","author":"Chonchaiya","year":"2010","journal-title":"Clin Genet."},{"key":"B90","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/NSS.S167658","article-title":"The prevalence and awareness of sleep apnea in patients suffering chronic pain: an assessment using the STOP-Bang sleep apnea questionnaire","volume":"10","author":"Tentindo","year":"2018","journal-title":"Nat Sci Sleep"},{"key":"B91","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0306-4522(02)00034-9","article-title":"GABA mechanisms and sleep","volume":"111","author":"Gottesmann","year":"2002","journal-title":"Neuroscience"},{"key":"B92","first-page":"77","article-title":"Sarzi-Puttini P. Fibromyalgia and autoimmune diseases: the pain behind autoimmunity","volume":"10","author":"Buskila","year":"2008","journal-title":"Isr Med Assoc J."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/ajmg.a.35569","article-title":"Immune-mediated disorders among women carriers of fragile X premutation alleles","author":"Winarni","year":"2012","journal-title":"Am J Med Genet A"},{"key":"B94","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/ajmg.a.36748","article-title":"Immune mediated disorders in women with a fragile X expansion and FXTAS","author":"Jalnapurkar","year":"2015","journal-title":"Am J Med Genet A"},{"key":"B95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1742-2094-10-43","article-title":"Neuroinflammation and psychiatric illness","volume":"10","author":"Najjar","year":"2013","journal-title":"J Neuroinflammation"},{"key":"B96","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12264-017-0103-8","article-title":"The immune system, cytokines, and biomarkers in autism spectrum disorder","volume":"33","author":"Masi","year":"2017","journal-title":"Neurosci Bull."},{"key":"B97","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1189\/jlb.0212100","article-title":"The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes","volume":"92","author":"Beumer","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jamaneurol.2015.1138","article-title":"Fragile X-associated tremor\/ataxia syndrome in a man in His 30s","volume":"72","author":"Mart\u00ednez-Cerde-o","year":"2015","journal-title":"JAMA Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuro.2016.01.008","article-title":"Phenoarbital use and neurological problems in FMR1 premutation carriers","volume":"53","author":"Saldarriaga","year":"2016","journal-title":"Neurotoxicology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1097\/ANA.0000000000000508","article-title":"General anesthetic use in Fragile X Spectrum Disorders","author":"Ligsay","year":"2018","journal-title":"J Neurosurg Anesthesio"},{"key":"B101","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10522-017-9718-4","article-title":"Mitochondrial biogenesis and neural differentiation of human iPSC is modulated by idebenone in a developmental stage-dependent manner","volume":"18","author":"Augustyniak","year":"2017","journal-title":"Biogerontology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fncel.2014.00463","article-title":"Mitochondrial protection by the mixed muscarinic\/\u03c31 ligand ANAVEX2-73, a tetrahydrofuran derivative, in A\u03b225-35 peptide-injected mice, a nontransgenic Alzheimer's disease model","volume":"8","author":"Lahmy","year":"2015","journal-title":"Front Cell Neurosci."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00564\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T03:13:29Z","timestamp":1542078809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00564\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":102,"alternative-id":["10.3389\/fpsyt.2018.00564"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2018.00564","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]},"article-number":"564"}}